Measuring health in inmates using a synthetic index: a study of a prison in central Italy
Keywords:
Italian prison, inmates, noncommunicable diseases, synthetic indexAbstract
Background: Global prison population has increased worldwide by approximately 24% since the 2000s. The objective of our study was to create a health status index for inmates at the L'Aquila prison and to describe their health profiles. Methods: The pathologies examined concerned: heart valves, arterial ischemia, cerebral vascular accidents, endocrine diseases, Type 2 diabetes, malignant and benign neoplasms. In addition, respiratory, kidney, urogenital, osteo-articular, gastrointestinal, neurological, anemia, otorhinolaryngology, ophthalmology, dermatological, dental, psychiatric disorders, and infectious diseases. A score was given to the therapies: 0-absence of therapy; 1-monotherapies; 2-polytherapies; 3-high-cost therapies. The health state was: good, fairly good, poor, compromised, severe, or loss of patient autonomy. The pathologies taken into consideration were introduced into the MCA model to highlight health profiles.
Results: The synthetic health index showed the following health status: good (25 cases, 15.9%), fairly good (104, 66.2%), poor (25, 15.9%), compromised (2, 1.3%) and severe (1, 0.6%).
The MCA identified three profiles. The first consisted of individuals aged ≥60, with the presence of arterial hypertension, respiratory diseases, cardiovascular diseases, endocrine diseases, neoplasms, and serious health status. The second, were inmates aged 50 to 59, with renal, gastrointestinal, neurological and infectious diseases, undergoing psychological treatment, with an average health status index. The third consisted of individuals under 50 with no underlying health conditions.
Discussion: prevention must be a priority among young people in good health, to prevent their well-being from declining to a fair level, and above all, to prevent further deterioration into mediocre conditions. In conclusion early intervention with preventive measures allows young prisoners to maintain optimal health, reducing the risk of developing chronic diseases or complications over time.
References
1. Raimer BG, Stobo JD. Health care delivery in the Texas prison system: the role of academic medicine. JAMA. 2004;292(4):485-9. doi:10.1001/jama.292.4.485
2. Altobelli E, Guergache AK, Galassi F, Petrocelli R, Marziliano C. Cost analysis of penitentiary systems and comparison between the countries of the Council of Europe. Economies. 2024;12(11):311. doi:10.3390/economies12110311
3. Maruschak LM, Berzofsky M, Unangst J. Medical problems of state and federal prisoners and jail inmates, 2011-12. Bur Justice Stat Spec Rep. 2015;1-23. doi:10.1037/e573002012-001
4. Ministero della Giustizia. Statistiche detenuti italiani e stranieri presenti e capienze per istituto aggiornamento al 31 gennaio 2020 [Italian and foreign prisoners present and capacities by institution - update of 31 January 2020]. Rome: Ministero della Giustizia; 2020. [Italian]. Available at: https://www.giustizia.it/giustizia/it/mg_1_14_1.page?contentId=SST245520&previsiousPage=mg_1_14 (Last accessed: 16 November 2022).
5. WHO SAGE. Roadmap for prioritizing uses of COVID-19 vaccines in the context of limited supply: an approach to inform planning and subsequent recommendations based on epidemiological setting and vaccine supply scenarios. Geneva: World Health Organization; 2020. Available at: https://apps.who.int/iris/handle/10665/342917 (Last accessed: 16 November 2022).
6. Moeller L, Stover H, Jurgens R, Gatherer A, Nikogosian H. Health in prisons: a WHO guide to the essentials in prison health. Geneva: World Health Organization; 2007. Available at: http://www.ristretti.it/areestudio/salute/zippati/oms_linee_guida_inglese.pdf (Last accessed: December 2025).
7. Voller F, Silvestri C, Martino G, Fanti E, Bazzerla G, Ferrari F, et al. Health conditions of inmates in Italy. BMC Public Health. 2016;16:1162. doi:10.1186/s12889-016-3830-2
8. Altobelli E, Galassi F, Mastrodomenico M, Frabotta F, Marzi F, Angelone AM, et al. SARS-CoV2 infection and comorbidity in inmates: a study of central Italy. Int J Environ Res Public Health. 2023;20(4):3079. doi:10.3390/ijerph20043079
9. Gray BJ, Craddock C, Couzens Z, Bain E, Dunseath GJ, Shankar AG, et al. Abundance of undiagnosed cardiometabolic risk within the population of a long-stay prison in the UK. Eur J Public Health. 2020;31:461-6. doi:10.1093/eurpub/ckaa187
10. Feron JM, Paulus D, Tonglet R, Lorant V, Pestiaux D. Substantial use of primary health care by prisoners: epidemiological description and possible explanations. J Epidemiol Community Health. 2005;59(8):651-5. doi:10.1136/jech.2004.022269
11. Fazel S, Baillargeon J. The health of prisoners. Lancet. 2011;377(9769):956-65. doi:10.1016/S0140-6736(10)61053-7
12. Verde L, Pagano AM, de Leo M, Vetrani C, Ambretti A, Lucania L, et al. Diet-related risk factors for chronic noncommunicable diseases in Italian prisoners: B.A.C.I. (Benessere All'interno delle Carceri Italiane, well-being inside the Italian prisons) project by the Italian Society of Penitentiary Medicine and Public Health (S.I.M.S.Pe. Societa Italiana di Medicina e Sanita Penitenziaria). Curr Nutr Rep. 2023;12(4):709-20. doi:10.1007/s13668-023-00502-y
13. D'Aurizio G, Caldarola A, Ninniri M, Avvantaggiato M, Curcio G. Sleep quality and psychological status in a group of Italian prisoners. Int J Environ Res Public Health. 2020;17(12):4224. doi:10.3390/ijerph17124224
14. Dashti HS, Scheer FA, Jacques PF, Lamon-Fava S, Ordovas JM. Short sleep duration and dietary intake: epidemiologic evidence, mechanisms, and health implications. Adv Nutr. 2015;6(6):648-59. doi:10.3945/an.115.008623
15. Engelgardt P, Bloch-Boguslawska E, Wolska E. Opinionating in cases of assessing the subject's ability to undergo imprisonment in materials collected by the Department of Forensic Medicine in Bydgoszcz in the years 1998-2003. Arch Med Sadowej Kryminol. 2006;56(3):173-80.
16. Romano CA, Ravagnani L, Convertini A, Dassisti L, Fanizza AR, Misceo F, et al. The aging process in prison: pathologies and health conditions in old inmates. Epidemiological research in Italy. Clin Ter. 2020;171:e340-5. doi:10.7417/CT.2020.2237
17. Enggist S, Moller L, Galea G, Udesen C, eds. Prisons and health. Copenhagen: WHO Regional Office for Europe; 2014. Available at: https://apps.who.int/iris/handle/10665/128603 (Last accessed: 25 February 2024).
18. Binswanger IA, Redmond N, Steiner JF, Hicks LS. Health disparities and the criminal justice system: an agenda for further research and action. J Urban Health. 2011;89(1):98-107. doi:10.1007/s11524-011-9614-1
19. Wright NM, Hearty P, Allgar V. Prison primary care and non-communicable diseases: a data-linkage survey of prevalence and associated risk factors. BJGP Open. 2019;3(2):bjgpopen19X101643. doi:10.3399/bjgpopen19X101643
20. Harvey TD, Busch SH, Lin HJ, Aminawung JA, Puglisi L, Shavit S, et al. Cost savings of a primary care program for individuals recently released from prison: a propensity-matched study. BMC Health Serv Res. 2022;22:585. doi:10.1186/s12913-022-07985-5
21. Moschetti K, Zabrodina V, Wangmo T, Holly A, Wasserfallen JB, Elger BS, et al. The determinants of individual health care expenditures in prison: evidence from Switzerland. BMC Health Serv Res. 2018;18:160. doi:10.1186/s12913-018-2962-8
22. Jowitt J, Severance J, Nnaka T, Knebl J. Geriatric justice: advocating for equity in healthcare for elderly populations in correctional facilities. Geriatr Nurs. 2025;62(Pt B):291-3. doi:10.1016/j.gerinurse.2024.12.005
23. Munday D, Leaman J, O'Moore E, Plugge E. The prevalence of non-communicable disease in older people in prison: a systematic review and meta-analysis. Age Ageing. 2018;48:204-12. doi:10.1093/ageing/afy186
24. Khalaf A. Smoking, prisons and human rights. Rev Esp Sanid Penit. 2023;25(2):43-4. doi:10.18176/resp.00066
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Emma Altobelli, Francesca Galassi, Ilenia Proietti, Reimondo Petrocelli, Ciro Marziliano (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.